$248.95+7.15% · 3M
Moving avg
1W-4.83%
1M+5.05%
3M+7.15%
6M+49.75%
YTD+43.77%
1Y+119.66%
3Y+77.82%
5Y+70.92%
52-week range
$105.0092% of range$262.00
Company health
Value3/6
Growth5/6
Profitability3/6
Health2/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (2137%)
- Revenue compounding 12% a year
Risks
- Currently unprofitable
Key statistics
Valuation
Market cap
$15.64B
Enterprise value
$15.87B
P/E ratio (TTM)
17.21x
P/S ratio (TTM)
3.57x
EV/EBITDA
10.75x
Per share & returns
EPS (TTM)
$14.89
Dividend yield
0.00%
Beta (1Y)
0.36
30-day change
+5.05%
Trading
Volume (24h)
549.06K
Previous close
$247.98
Shares outstanding
62.82M
About Jazz Pharmaceuticals plc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
JAZZ
Jazz Pharmaceuticals plc is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ under the ticker JAZZ.
Frequently asked questions
What is Jazz Pharmaceuticals plc's market cap?
Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $15.64B.
What is Jazz Pharmaceuticals plc's P/E ratio?
Jazz Pharmaceuticals plc trades at a price-to-earnings (P/E) ratio of 17.21.
What exchange does JAZZ trade on?
JAZZ trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 363.40-0.57%
$355.88B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.68-0.42%
$289.21B cap
AstraZeneca PLCLON: AZN
£116.36-0.56%
$243.29B cap